Each year over 2500 drug development executives convene at Partnerships in Clinical Trial meetings all over the world in the US, Latin America, Europe and now China.

Conducting clinical research in Asia is no longer simply a strategy to improve timelines and cost-savings – it is the only way to maintain a globally competitive pipeline.

Join the largest concentration of clinical decision makers specializing in clinical development, operations and outsourcing to establish benchmarks, standards and next practices in clinical development and commercialization of products in a global marketplace.

	International Pharma John Hubbard Senior Vice President, Global Drug Development, Pfizer		Leading Regional Pharma Chris Chen Chief Executive Officer, Shanghai Celgen
	International Pharma Ross Horsburgh Vice President Clinical Development, Nycomed		Leading Regional Pharma Lee Chichang Executive Director, Simcere Pharmaceuticals
	International Pharma Shirley Zhao Managing Director, China, Genzyme		Leading Regional Pharma Helen Jiang Vice President Clinical, Jiangsu Hengrui Medicine Company

Plus: Hear directly from the SFDA!

Wenming Du, Executive Director, Shanghai Center for Adverse Drug Reaction Monitoring of the SDFA

TOP REASONS WHY YOU SHOULD JOIN US IN SHANGHAI!

• Hear in-depth case studies on strategic partnering and effective outsourcing to ensure quality, control costs and accelerate cures to market
• Explore new business opportunities and strategies to bring more innovation to Asia
• Hear from the SFDA on updates on clinical safety and monitoring guidelines
• Understand how global clinical leaders are incorporating China into their global drug development strategy
• Gain insights into the regulatory landscapes in Japan, India, Korea, Taiwan, China, and more
• Obtain strategies for partnering in specific therapeutic areas by hearing proven case studies in oncology, CNS, Cardiovascular, and vaccine development
• Develop strategies to improve sponsor, CRO, and site collaborations in Asia
• Learn about trends in patient recruitment efforts across the region and develop strategies to suit Asian cultures
• Examine level of data quality in the region and overcome challenges in GCP implementation
• Identify new trends in technology impacting clinical development in Asia and exchange best practices on data management